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Lower levels of hemoglobin A1c (HbA1c) are associated with a decreased risk of cardiovascu-
lar complications in diabetic and non-diabetic individuals. The aim of the study was to longitu-
dinally investigate the association between the use of 11 vitamins and minerals (vitamins E,
C, D, B1, folic acid, carotenoids, calcium, magnesium, zinc, iron, and selenium) and change in
HbA1c levels over 10 years in non-diabetic individuals drawn from the general population.
Methods
Baseline data were available from 4447 subjects included in the population-based “Monitoring
of Trends and Determinants in Cardiovascular Diseases” (MONICA) Augsburg S3 survey
(1994/95). Follow-up data were derived from 2774 participants in the follow-up survey named
“Cooperative Health Research in the Region of Augsburg” (KORA) F3 (2004/05). Vitamin/min-
eral intake from supplements andmedications was assessed in a personal interview, where
participants were asked to bring product packages of preparations that had been ingested dur-
ing the last 7 days prior to the examination. Associations between regular vitamin/mineral intake
amounts and HbA1c levels measured at baseline and follow-up were investigated using gener-
alized estimating equation models. For carotenoids, analyses were stratified by smoking status.
Results
None of the investigated nutrients except for carotenoids was significantly associated with
changes in HbA1c levels after 10 years. Regular intake of carotenoids from supplements
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and medications in amounts > 6.8mg/d (upper tertile) was associated with an absolute –
0.26% (95% CI: –0.43 to –0.08) lower increase in HbA1c levels compared with no intake of
carotenoids. An inverse association was observed in those who never smoked but not in
(former) smokers.
Conclusion
Larger prospective and intervention studies in non-diabetic/non-smoking individuals are
needed to confirm the results and to assess whether the observed associations between
carotenoid intake and change in HbA1c levels are causal. If our results are confirmed, high
carotenoid intake could be one strategy for the prevention of cardiovascular complications
in non-diabetic people.
Introduction
Hemoglobin A1c (HbA1c) reflects the percentage of glycated hemoglobin, which results from
non-enzymatic attachment of glucose to hemoglobin. Levels of HbA1c indicate the long-term
average blood glucose level over the previous 8–12 weeks [1]. Values 6.5% can be used for
the diagnosis of diabetes [2]. Besides its use as a diagnostic tool, HbA1c has been investigated as
a marker for cardiovascular risk. An increase in HbA1c levels of 1% is associated with a 17%
increase in risk of cardiovascular disease and a 15% increase in risk of all-cause mortality in
subjects with type 2 diabetes [3]. The increased risk of cardiovascular complications with
higher HbA1c levels is not only evident in those with established diabetes, but also in non-dia-
betic adults [4–7]. In the latter, HbA1c levels are more strongly associated with coronary heart
disease risk than other glycemic measures [8], and all-cause mortality risk increases by 26%
with a 1% increase in HbA1c concentration [9]. Therefore, HbA1c should be investigated con-
tinuously in the assessment of cardiovascular and mortality risk [9].
Previous studies on the association between vitamins/minerals and HbA1c levels investi-
gated the effect of vitamin E, vitamin C, vitamin D, vitamin B1, folic acid, carotenoids (β-caro-
tene), calcium, magnesium, zinc, iron, and selenium [10–33]. For most nutrients, the results
were not consistent between studies that investigated the same nutrients as exposure. Further-
more, all the above mentioned intervention studies were conducted in diabetic patients or high
risk populations [10–27]. However, supplementation of nutrients might be less effective if the
disease has already developed [11,14]. Therefore, investigations in non-diabetic populations
are warranted. Population-based studies conducted to date have been of cross-sectional design
[28,29,32,33], which precludes conclusions regarding causal relationships. Considering that
chronic diseases develop over a period of several years, it is particularly important to conduct
long-term studies to investigate potential prevention strategies.
To our knowledge, there is currently no population-based longitudinal study of the associa-
tion between the use of different vitamin or mineral supplements and change in HbA1c levels
in the general healthy population. As the use of dietary supplements could be a promising and
feasible strategy to prevent hyperglycemia related complications, the aim of the study was to
investigate the longitudinal relationship between the intake of vitamins/minerals from supple-
ments and medications with HbA1c concentrations over 10 years in a population-based sample
of non-diabetic people.
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Methods
Study description and population
Baseline data were available from the population-based Monitoring of Trends and Determi-
nants in Cardiovascular Diseases (MONICA) Augsburg S3 survey conducted in the years
1994/95 as part of the international World Health Organization (WHO) MONICA project
[34]. The study region comprised the city of Augsburg (Germany) and its two surrounding
counties. A total of 6640 participants aged 25–74 years were randomly selected by a two-stage
cluster sampling method, of whom 4856 participated (73.1%) [35]. Of these, 3006 participants
took part in the subsequent Cooperative Health Research in the Region of Augsburg (KORA)
F3 survey after 10 years of follow-up [36]. After exclusion of diabetic individuals at baseline,
either clinically diagnosed (n = 241) or with baseline HbA1c levels 6.5% (n = 57), those who
ingested antidiabetic medication at baseline or follow-up (n = 109), and participants with miss-
ing HbA1c values at baseline and follow-up (n = 2), the final study population comprised 4447
subjects at baseline and 2774 at follow-up.
The study was conducted according to the guidelines laid down in the Declaration of Hel-
sinki, and all procedures involving human subjects were approved by the ethics committee of
the Bavarian Chamber of Physicians (Munich, Germany). Written informed consent was
obtained from all participants.
Data collection
Outcome. The outcome HbA1c was assessed at baseline (1994/95) and at follow-up (2004/
05). Non-fasting blood samples were collected according to a standardized procedure. HbA1c
was measured with turbidimetric immunoassays (Tina-quant1Hämoglobin A1c, Boehringer
Mannheim, Mannheim, Germany, and Dimension Rxl 5 Dade-Behring (TINA) with coeffi-
cients of variation (CVs)< 5%) at baseline and follow-up. HbA1c was treated as a continuous
variable in all analyses.
Exposure. Intake of vitamins/minerals from supplements and medications was assessed in
a personal interview at baseline (1994/95) and follow-up (2004/05) and also in between after 3
years from baseline investigation through a self-administered postal questionnaire in 2998
individuals (1997/98). Data from the postal questionnaire were only used for descriptive pur-
poses. In the baseline and follow-up surveys, participants were asked to bring all product pack-
ages of preparations that were ingested during the last 7 days prior to the examination to the
study center. In MONICA S3 (1994/95), the information was recorded through a question-
naire. In KORA F3 (2004/05), database supported computer software (IDOM: Instrument for
databased assessment of medication) [37] was used. Daily amounts of regularly ingested nutri-
ents per person were calculated for each survey from a database established by staff at the
Helmholtz Zentrum München, which has been updated regularly [38]. Both total carotenoids
and β-carotene intakes were investigated, but we restricted our main analyses to carotenoids, as
the number of missing values was lower here.
Regular intake of each nutrient was investigated by dividing average intake amount per day
into tertiles. Additionally, intake was analyzed binarily (regular vs no intake). For all analyses,
the reference group comprised those who did not take the specific nutrient of interest. Cut-off
points for tertiles were built from the means of the cut-off points from daily intake amounts at
baseline and follow-up (see S1 Table).
Potential confounders. In both surveys, data regarding sex, age, physical activity, smoking
status, alcohol intake, healthy diet, and medication intake were collected during a standardized
face-to-face interview by trained medical staff [36]. For information on years of education and
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family history of diabetes, i.e., diabetes of the mother or father, only the baseline survey was
considered. Participants who did not know whether their mother or father suffered or died
from diabetes were added to the group that answered this question with “yes”. Education was
defined through a combination of years of schooling and professional education and divided
into a low (8–10 years) and high (11–17 years) level of education. Physical activity included fre-
quency and duration of activity in summer and winter and was divided into four categories.
Smoking status was divided into current (regular and irregular), former, and never smoking.
Alcohol intake during the last week was assessed, and an average daily intake amount was cal-
culated based on the alcohol intake during the last weekend and the last weekday prior to each
examination. Sex-specific categories were created as follows: moderate intake (> 0 to< 20 g
alcohol per day (g/d) (women) and> 0 to< 40 g/d (men)), high intake ( 20 g/d (women)
and 40 g/d (men)), and no intake (0 g/d (men and women)). A food frequency questionnaire
with 15 food items was used to build a healthy diet score according to the recommendations of
the German Nutrition Society 1989 with higher values representing a healthier diet [39]. As
food intake was only assessed through a short food frequency questionnaire in the total study
sample which did not allow us to calculate intake levels for individual nutrients from diet, we
restricted our analyses to intake of nutrients from dietary supplements. Medication that
increased HbA1c levels included beta-blockers, diuretics, and regular intake of systemic
corticoids.
Anthropometric data (body mass index (BMI), waist–hip ratio (WHR)), information on
hypertension, and cholesterol levels were collected during health examinations by trained med-
ical staff. To calculate the BMI, participants’ weight and height were measured, and categories
were applied according to the WHO. The WHR was calculated as the ratio between waist and
hip circumferences and categorized as low (men< 1, women< 0.85) and high (men 1,
women 0.85). Hypertension was defined as a systolic blood pressure 140 mmHg and/or
diastolic blood pressure 90 mmHg or if the participant was taking antihypertensive medica-
tion and was aware of being hypertensive. Total and high density lipoprotein (HDL) choles-
terol were measured using the CHOD-PAP method (Dade Behring) with CVs< 5% at baseline
and follow-up.
Statistical analyses
Age- and sex-adjusted mean levels of HbA1c by categories of covariables and exposure variables
were compared using analysis of covariance. To account for the intra-individual correlation,
generalized estimating equation (GEE) models using the compound symmetry correlation
structure were performed by the Statistical Analysis Systems (SAS) procedure GENMOD for
investigation of the long-term association between vitamin/mineral intake from supplements/
medications and HbA1c levels. As results, the beta estimates of the interaction terms of each
nutrient tertile of interest with time (coded 0/1) are presented (βx). These reflect the difference
in change in HbA1c levels between the nutrient tertile of interest and the reference group. Fur-
thermore, beta estimates of time are displayed, which reflect the average change in HbA1c levels
in the reference group (βt). Estimates for each nutrient tertile of interest show the difference in
HbA1c levels at baseline compared with the reference group (β0).
Continuous covariates were investigated continuously if their association with the outcome
was linear in cross-sectional analysis using univariable linear regression models; otherwise,
they were categorized. The following variables were included in the models as potential con-
founders: sex, age (continuously), education (high/low), BMI (three groups), WHR (two
groups), physical activity (four groups), smoking (three groups), alcohol intake (three sex-spe-
cific categories), healthy diet score (continuously), total/HDL cholesterol (continuously), actual
Vitamin/Mineral Supplements and Long-Term HbA1c
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hypertension (yes/no), diabetes of the father (yes/no), diabetes of the mother (yes/no), intake
of HbA1c increasing medication (yes/no).
The level of statistical significance was Bonferroni corrected and set at p< 0.0045 (11 inves-
tigated nutrients). Statistical analyses were performed using SAS version 9.3 (SAS Institute Inc,
Cary, NC, USA).
Sensitivity analyses
As sensitivity analyses, individuals were excluded who 1) developed diabetes during the
10-year follow-up period (n = 142); and 2) had baseline HbA1c levels> 5.7% (n = 354) [40], as
supplementation of nutrients in those with impaired glucose regulation might already be too
late to exert beneficial effects [14]. Furthermore, stratified analyses according to smoking status
were conducted to investigate the association between carotenoid intake and HbA1c levels,
because detrimental effects of β-carotene have been reported in smokers [41]. We also con-
ducted longitudinal analyses only in those without any missing values in vitamin/mineral
intake and HbA1c values at baseline and follow-up (n = 2630).
Results
Descriptive analyses
Unadjusted mean (standard error of the mean, SEM) HbA1c levels in the study population
were 5.12 (0.01) at baseline (n = 4133) and 5.28 (0.01) at follow-up (n = 2774). Description of
adjusted mean HbA1c levels by participant characteristics is provided in Table 1. Adjusted
mean levels of HbA1c according to exposure categories are presented in Table 2. Regular intake
of each investigated nutrient increased constantly from baseline over the 3-year to the 10-year
follow-up (see S1 Fig). The proportion of individuals with constant regular intake of nutrients,
i.e., regular intakes at baseline and follow-up, in relation to those with regular intake of that
nutrient at baseline ranged between 10.0% (iron) and 31.0% (selenium).
Main analysis
After 10 years, the HbA1c levels of participants who comprised the reference group (no intake)
for each investigated nutrient increased by about 0.1% from baseline (see βt in Table 3). Partici-
pants with carotenoid intakes in the upper tertile had a 0.26% lower increase in HbA1c values
after 10 years than those with no intake of carotenoids (see βx in Table 3). It is noteworthy that
participants with carotenoid intakes in the upper tertile had 0.22% higher HbA1c levels at base-
line compared with the reference group (see β0 in Table 3), even though this difference was
marginally not statistically significant after Bonferroni correction (p = 0.005). The intake of
none of the other investigated nutrient tertiles was significantly associated with concentrations
of HbA1c after correction for multiple testing (see Table 3). Treating the exposure to regular
intake of each nutrient as binary variables (regular intake vs no intake) yielded analogous find-
ings, whereas the association of regular carotenoid intake with HbA1c levels was not statistically
significant (data not shown).
Sensitivity analyses
Excluding 142 participants who developed diabetes during the 10-year follow-up resulted in
similar findings to the main analysis, apart from the fact that the inverse association between
the upper carotenoid tertile and change in HbA1c levels was not statistically significant (data
not shown). Like in the main analysis, after exclusion of 354 participants with baseline HbA1c
levels> 5.7%, the increase in HbA1c levels in individuals with intakes of carotenoids in the
Vitamin/Mineral Supplements and Long-Term HbA1c
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Table 1. Characteristics of the study population with adjusted mean levels of HbA1c at baseline (1994/95) and follow-up (2004/05).
Baseline (1994/95) Follow-up (2004/05)




25–34 893 833 4.97 (0.01) 592 589 5.13 (0.01)
35–44 949 892 5.04 (0.01) 674 671 5.22 (0.01)
45–54 904 867 5.13 (0.01) 649 649 5.31 (0.01)
55–64 910 840 5.20 (0.01) 558 557 5.37 (0.01)
65–74 791 701 5.31 (0.02) 301 300 5.49 (0.02)
Sex <0.001 0.290
Male 2187 2093 5.04 (0.01) 1342 1338 5.28 (0.01)
Female 2260 2040 5.21 (0.01) 1432 1428 5.29 (0.01)
Education 0.009 <0.001
Low 2526 2339 5.14 (0.01) 1445 1442 5.32 (0.01)
High 1920 1794 5.10 (0.01) 1329 1324 5.25 (0.01)
BMI (kg/m2) <0.001 <0.001
< 25 1611 1498 5.10 (0.01) 863 861 5.22 (0.01)
 25 to < 30 1922 1817 5.12 (0.01) 1210 1207 5.28 (0.01)
 30 866 793 5.18 (0.02) 680 679 5.37 (0.01)
Waist–hip ratio 0.104 <0.001
High 646 575 5.15 (0.02) 728 728 5.39 (0.01)
Low 3762 3538 5.12 (0.01) 2033 2027 5.25 (0.01)
Physical activity 0.006 <0.001
Very active 883 835 5.10 (0.01) 635 635 5.24 (0.01)
Moderately active 1074 1018 5.11 (0.01) 827 823 5.27 (0.01)
Less active 663 637 5.10 (0.02) 413 413 5.32 (0.02)
Inactive 1825 1642 5.15 (0.01) 891 889 5.31 (0.01)
Smoking 0.571 0.087
Current 1140 1067 5.14 (0.01) 527 526 5.31 (0.02)
Former 1348 1263 5.12 (0.01) 1015 1012 5.28 (0.01)




None 1440 1305 5.16 (0.01) 768 766 5.34 (0.01)
Moderate 2050 1929 5.13 (0.01) 1439 1436 5.28 (0.01)
High 956 898 5.07 (0.01) 557 556 5.22 (0.01)
Healthy diet 0.786 0.356
Unfavorable 1348 1258 5.13 (0.01) 682 680 5.27 (0.01)
Normal 904 848 5.12 (0.01) 424 423 5.26 (0.02)
Favorable 2190 2023 5.12 (0.01) 1358 1356 5.25 (0.01)
Hypertension 0.679 <0.001
Yes 1733 1598 5.12 (0.01) 1306 1303 5.31 (0.01)




< 3.5 1216 1158 5.08 (0.01) 1169 1169 5.24 (0.01)
 3.5 to < 5.0 1631 1578 5.12 (0.01) 1061 1060 5.29 (0.01)
 5.0 1456 1394 5.17 (0.01) 537 537 5.36 (0.01)
(Continued)
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upper tertile was significantly lower (βx = –0.29% (95% CI: –0.45 to –0.12)) compared with
individuals with no intake of carotenoids (p = 0.0006). Unlike in the main analysis, the differ-
ence in baseline HbA1c levels of 0.25% (95% CI: 0.11 to 0.39) between those with the highest
intakes of carotenoids compared with those with no intake was statistically significant.
In the smoking status-stratified analyses of carotenoid intake and HbA1c levels, the results
for current and former smokers were pooled together, as they did not differ substantially (data
not shown). A longitudinal inverse association of the upper carotenoid tertile with HbA1c level
was significant in participants who never smoked (βx = –0.43% (95% CI: –0.63 to –0.24),
p< 0.0001), but not in current or former smokers (βx = –0.11% (95% CI: –0.39 to 0.17),
p = 0.451) (see Fig 1). Never smokers with carotenoid intakes in the upper tertile had higher
baseline HbA1c values than never smokers with no intake of carotenoids (β0 = 0.33 (95% CI:
0.18 to 0.48), p< 0.0001).
The results when restricting the study population to participants without any missing values
in exposure and outcome at baseline and follow-up were similar to the main analysis (data not
shown).
Discussion
We investigated the longitudinal association of regular intake of vitamin E, vitamin C, vitamin
D, vitamin B1, folic acid, carotenoids, calcium, magnesium, zinc, iron, and selenium from sup-
plements and medications with levels of HbA1c in the general non-diabetic population. The
results indicate that there is an inverse association of regular carotenoid intakes above 6.8 mg/d
with concentrations of HbA1c after 10 years and no significant association of intake of the
other investigated vitamins and minerals with HbA1c levels. The observed reduction of 0.3
absolute percentage points in HbA1c levels in the upper carotenoid tertile can be regarded as
clinically relevant, as a reduction of 0.1% in the general non-diabetic population could lead to a
reduction in mortality of up to 6% over a period of 6 years [9].
Table 1. (Continued)
Baseline (1994/95) Follow-up (2004/05)




Yes 1136 1054 5.16 (0.01) 696 694 5.31 (0.01)




Yes 937 874 5.17 (0.01) 544 542 5.32 (0.01)
No 3508 3257 5.11 (0.01) 2229 2223 5.27 (0.01)
HbA1c " medication 0.736 <0.001
Yes 555 499 5.13 (0.02) 677 675 5.34 (0.01)
No 3888 3630 5.12 (0.01) 2090 2086 5.26 (0.01)
BMI = body mass index, HbA1c = hemoglobin A1c, HDL = high density lipoprotein, SEM = standard error of the mean
*age- and sex-adjusted mean HbA1c, for adjustment age was treated continuously, age was only sex adjusted, sex was only age adjusted
**p for adjusted mean difference (analysis of covariance); numbers of people in categories in column “n Total” do not sum up to the number in the total
study population because of missing values.
doi:10.1371/journal.pone.0139244.t001
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Table 2. Adjustedmean levels of HbA1c by categories of exposure variables at baseline (1994/95) and follow-up (2004/05).
Baseline (1994/95) Follow-up (2004/05)
Nutrient Category n Total (4447) n HbA1c (4133) HbA1c (SEM)* p-value** n Total (2774) n HbA1c (2766) HbA1c (SEM)* p-value**
Vitamin E 0.256 0.934
No intake 4037 3744 5.13 (0.01) 2321 2316 5.28 (0.01)
Tertile 1 104 97 5.18 (0.04) 126 126 5.28 (0.03)
Tertile 2 84 81 5.11 (0.05) 132 132 5.26 (0.03)
Tertile 3 88 80 5.04 (0.05) 148 147 5.27 (0.03)
Vitamin C 0.456 0.410
No intake 3882 3597 5.13 (0.01) 2255 2249 5.29 (0.01)
Tertile 1 119 112 5.13 (0.04) 163 163 5.27 (0.03)
Tertile 2 80 75 5.14 (0.05) 107 107 5.23 (0.03)
Tertile 3 114 108 5.06 (0.04) 136 136 5.29 (0.03)
Vitamin D 0.764 0.049
No intake 4328 4026 5.13 (0.01) 2500 2494 5.29 (0.01)
Tertile 1 30 26 5.06 (0.08) 45 45 5.17 (0.05)
Tertile 2 42 38 5.09 (0.07) 148 148 5.30 (0.03)
Tertile 3 15 14 5.05 (0.11) 50 50 5.24 (0.05)
Vitamin B1 0.873 0.491
No intake 4101 3810 5.13 (0.01) 2453 2447 5.28 (0.01)
Tertile 1 83 79 5.16 (0.05) 122 122 5.28 (0.03)
Tertile 2 53 49 5.09 (0.06) 62 62 5.23 (0.04)
Tertile 3 88 78 5.09 (0.05) 90 90 5.31 (0.04)
Folic acid 0.291 0.745
No intake 4204 3901 5.13 (0.01) 2437 2431 5.28 (0.01)
Tertile 1 53 50 5.10 (0.06) 62 62 5.32 (0.04)
Tertile 2 55 55 5.13 (0.06) 126 126 5.27 (0.03)
Tertile 3 37 33 4.97 (0.07) 106 106 5.29 (0.03)
Carotenoids 0.199 0.420
No intake 4375 4066 5.12 (0.01) 2608 2602 5.28 (0.01)
Tertile 1 18 16 5.02 (0.11) 40 40 5.31 (0.05)
Tertile 2 13 13 5.11 (0.12) 58 58 5.28 (0.04)
Tertile 3 18 17 5.33 (0.10) 46 46 5.20 (0.05)
Calcium 0.778 0.678
No intake 4073 3789 5.12 (0.01) 2398 2392 5.28 (0.01)
Tertile 1 106 98 5.10 (0.04) 69 69 5.25 (0.04)
Tertile 2 93 87 5.14 (0.05) 121 121 5.27 (0.03)
Tertile 3 63 56 5.12 (0.06) 131 131 5.28 (0.03)
Magnesium 0.652 0.118
No intake 3963 3681 5.13 (0.01) 2253 2247 5.29 (0.01)
Tertile 1 133 124 5.14 (0.04) 122 122 5.26 (0.03)
Tertile 2 132 121 5.07 (0.04) 155 155 5.24 (0.03)
Tertile 3 75 72 5.12 (0.05) 144 144 5.32 (0.03)
Zinc 0.329 0.794
No intake 4365 4060 5.12 (0.01) 2480 2475 5.28 (0.01)
Tertile 1 46 40 5.09 (0.07) 41 41 5.27 (0.05)
Tertile 2 1 1 4.49 (0.42) 10 10 5.26 (0.11)
Tertile 3 8 8 5.30 (0.15) 202 201 5.27 (0.02)
Iron 0.886 0.345
No intake 4303 4005 5.13 (0.01) 2605 2599 5.28 (0.01)
Tertile 1 32 29 5.09 (0.08) 103 103 5.27 (0.03)
(Continued)
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Comparison with the literature
Previous intervention studies examining the effect of use of vitamins/minerals on HbA1c levels
have mostly been conducted in diabetic or prediabetic subjects and found inconsistent results.
Significant inverse associations with HbA1c levels were reported for vitamins E, C, D, B1, folic
acid, calcium, magnesium, zinc, iron, and selenium supplemented either alone or in combina-
tion [12,19,21,22,24,26,42]. Other intervention studies found no significant associations for
vitamins E, C, D, B1, folic acid, carotenoids, calcium, magnesium, and zinc [10,11,13–
15,17,18,20,23,25]. In contrast, significant positive associations were also observed for vitamin
D, folic acid, and selenium [16,27,43].
Inadequacy of baseline nutrient status might influence the efficacy of supplementation, as
single studies that reported a protective role for supplemented nutrients (iron, vitamin D with
calcium) were conducted in those with inadequate baseline status [21,26]. Furthermore, a
recently published meta-analysis on vitamin E supplementation found that HbA1c lowering
effects might rather be present in people with low baseline vitamin E status [10]. The same
study reported that vitamin E dosages above 400 mg/d might be necessary to result in
decreased HbA1c levels. In the present study, two thirds of all subjects who regularly supple-
mented vitamin E ingested daily amounts of less than 66 mg.
One explanation for the null findings in some of the above mentioned studies is that all
were conducted in (pre-)diabetic or high risk populations. The state of dysglycemia might
already be too advanced to facilitate beneficial effects of vitamin supplementation [11,14].
Therefore, further intervention studies are warranted in non-diabetic and also in non-predia-
betic individuals to investigate the relationship between vitamin/mineral intake and HbA1c
levels.
Carotenoids
In the present study, regular intake of> 6.8 mg of carotenoids per day from supplements and
medications, which corresponds to the upper tertile, was associated with an about 0.3% lower
increase in HbA1c concentrations after 10 years. Similar dose–effect results were presented by
Akbaraly et al. from the Epidemiology of Vascular Ageing (EVA) study; however, they investi-
gated plasma carotenoid levels as exposure with regard to other diabetes related outcomes in
Table 2. (Continued)
Baseline (1994/95) Follow-up (2004/05)
Nutrient Category n Total (4447) n HbA1c (4133) HbA1c (SEM)* p-value** n Total (2774) n HbA1c (2766) HbA1c (SEM)* p-value**
Tertile 2 19 17 5.07 (0.10) 16 16 5.17 (0.08)
Tertile 3 59 51 5.09 (0.06) 23 23 5.24 (0.07)
Selenium 0.845 0.201
No intake 4404 4093 5.13 (0.01) 2569 2563 5.29 (0.01)
Tertile 1 5 5 5.01 (0.19) 112 112 5.25 (0.03)
Tertile 2 13 12 5.10 (0.12) 27 27 5.27 (0.07)
Tertile 3 11 11 5.09 (0.13) 37 37 5.29 (0.06)
HbA1c = hemoglobin A1c, SEM = standard error of the mean
*age- and sex-adjusted mean HbA1c, for adjustment age was treated continuously
**p for adjusted mean difference (analysis of covariance); numbers of people in categories in column “n Total” do not sum up to the number in the total
study population because of missing values and because subjects with intakes as needed are not listed.
doi:10.1371/journal.pone.0139244.t002
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elderly volunteers [44]. They found that the risk of dysglycemia was significantly lower in the
highest plasma carotenoid quartile after 9 years of follow-up.
Prospective studies on the association of carotenoids (intake or plasma/serum levels) with
HbA1c levels as an outcome have not, to our knowledge, been published so far. Cross-sectional
studies in healthy subjects reported an inverse association [31,32], or no association [30]. A
randomized controlled trial (RCT) detected no significant effect with regard to lowering of
HbA1c levels [13]. However, the trial was conducted in people with type 2 diabetes [13]. To our
knowledge, there is currently no RCT that investigated the effect of carotenoids on HbA1c lev-
els in healthy individuals. Also, the safety of carotenoid supplementation in higher dosages has
to be confirmed in future studies, as detrimental effects have been found for β-carotene not
only in smokers with dosages above 20 mg/d [41], but also in a pooled analysis of diverse
Fig 1. Longitudinal association between regular carotenoid intake amount from supplements andmedications in tertiles and levels of HbA1c over
10 years (1994/95 to 2004/05). nTotal population = 4447, nnever smokers = 1959, n(former) smokers = 2498; 10 people who stated they were never smokers at
baseline but smokers at follow-up were partly used for both strata for the appropriate time point; HbA1c beta estimates (βx) result from fully adjusted
generalized estimating equation models and refer to interaction terms with time (represents the difference in change in HbA1c levels compared with those
with no intake of carotenoids, see βx in Table 3 for total population); cut-off point for tertiles 1 and 2: 1.9 mg/d; for tertiles 2 and 3: 6.8 mg/d.
doi:10.1371/journal.pone.0139244.g001
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populations with dosages ranging from 15 to 50 mg/d [45]. The main carotenoid ingested in
the present study population was β-carotene. Some 98.0% and 68.1%, respectively, of all those
who regularly ingested carotenoids at baseline and follow-up took β-carotene. Mean (SD)
intake amount in the upper tertile of carotenoids was 15.4 (9.2) mg with a maximum value of
50 mg.
Mechanism. A potential mechanism for a HbA1c lowering effect of carotenoids might be
their antioxidant activity [46], which is closely related to protein glycosylation [47]. However,
controlling for several antioxidative markers in the EVA study mentioned above did not
change the result of a lower risk of dysglycemia with higher plasma carotenoids [44]. Further-
more, intake of the other investigated antioxidants (vitamin E, vitamin C, zinc, and selenium)
from supplements or medications was not significantly associated with lower HbA1c values in
the present investigation. Recently, Bumke-Vogt et al. [48] reported that, apart from caroten-
oids, another subgroup of phytochemicals resulted in down-regulation of gluconeogenic gene
expression in human hepatoma cells, an effect not attributed to their antioxidant activity [48].
This suggests that phytochemicals might exert other effects than hitherto known.
Smoking status. Stratified analyses according to smoking status showed that an inverse
association of carotenoids and HbA1c levels is only present in those who have never smoked.
These results support previous findings by Hozawa et al., who investigated serum carotenoid
levels as exposure and diabetes incidence and insulin concentrations as outcomes in the Coro-
nary Artery Risk Development in Young Adults (CARDIA) study [49]. The authors concluded
that higher serum carotenoid levels are significantly associated with a lower risk of diabetes
and insulin resistance after 15 years only in non-smokers, but not in smokers.
Strengths and limitations
A limitation of the present study is that measurements of HbA1c and covariables were only
available for two time points. Intake of supplements was assessed at three time points. Further-
more, there were no detailed data available on nutrient intakes from diet, and we only adjusted
for a diet score that represents a healthy or an unhealthy eating pattern. However, we believe
that dietary habits remained rather constant during the study period, as the categorized healthy
diet score remained the same in 56% of the participants with available information at baseline
and follow-up. An important limitation is the small (and also unequal) number of participants
in some nutrient tertiles, which might have underpowered the present analyses. Furthermore,
variation in baseline HbA1c levels was high in specific tertile groups, and the results might be
driven by outliers. Moreover, plasma levels were not measured, although these do not always
represent intake of nutrients, especially if a high turnover is present, such as with antioxidant
levels in smokers [50]. Inadequacy of baseline status of nutrients was not considered in the
present analysis, but might influence the efficacy of supplementation [10,21,26]. With respect
to vitamin E, ingested dosages might have been too low. Another important point to consider
is that participants with the highest intakes of carotenoids at baseline had relatively high base-
line levels of HbA1c. Therefore, regression to the mean might be present and might lead to
biased results with regard to the inverse longitudinal association. We also cannot exclude the
possibility that the results are due to residual confounding, as this is an observational study,
even if the beta estimates did not differ greatly between the raw and fully adjusted models.
The strengths of the present study include the long follow-up duration of 10 years, the avail-
ability of important covariables not only at baseline but also at follow-up, and the thorough
assessment of vitamin/mineral intake from supplements and medications. The availability of
average daily intake amounts of nutrients allowed the conduct of dose–effect analyses, which
are crucial in the investigation of physiological nutrient effects. Furthermore, this represents a
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population-based study of healthy non-diabetic individuals. Therefore, the results can be trans-
ferred to the general population. Finally, HbA1c exhibits a lower biological variability compared
with other glycemic outcomes [51] and is strongly associated with cardiovascular disease risk
in non-diabetic people [8].
Future perspectives
Larger prospective studies on vitamin/mineral intake or blood levels and HbA1c concentrations
are needed to confirm the results of the present analyses. If the results regarding a significant
inverse association of higher carotenoid intakes with HbA1c levels are replicated, RCTs can be
conducted, especially in non-smokers and those without diabetes, to investigate the causal
effect of carotenoid dosages> 6.8 mg/d in lowering HbA1c concentrations. If these studies con-
firm the present findings, supplementation of carotenoids might be a useful strategy in pre-
venting the development of type 2 diabetes as well as cardiovascular complications and
mortality in the general or non-smoking population.
Supporting Information
S1 Fig. Regular intake of dietary supplements over 10 years. Data are derived from the
MONICA (Monitoring of Trends and Determinants in Cardiovascular Diseases) S3 survey in
1994/95 (n = 4447), from a postal questionnaire in 1997/98 (n = 2998), and from the KORA
(Cooperative Health Research in the Region of Augsburg) F3 survey in 2004/05 (n = 2774); all
surveys longitudinally investigated the same individuals.
(TIF)
S1 Table. Cut-off points of daily intake amounts for building tertiles in baseline and fol-
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